Patents
Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
05/2009
05/28/2009US20090136499 RAF Inhibitors and Uses Thereof
05/28/2009US20090136448 Antiviral 2-Carboxy-Thiophene Compounds
05/28/2009CA2722591A1 Substituted benzoazole pde4 inhibitors for treating pulmonary and cardiovascular disorders
05/28/2009CA2722586A1 Substituted benzoazole pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders
05/28/2009CA2706586A1 Novel compounds as cannabinoid receptor ligands and uses thereof
05/27/2009EP2062893A1 Fused imidazoles for cancer treatment
05/27/2009EP2061794A2 2-phenoxy pyrimidinone analogues
05/27/2009EP2061771A1 Aspartyl protease inhibitors containing a tricyclic ring system
05/27/2009EP2061765A2 Serine-threonine protein kinase and parp modulators
05/27/2009EP1095275B1 Endogenous constitutively activated g protein-coupled orphan receptors
05/27/2009CN101443335A Thiazolyl dihydro-indazoles
05/27/2009CN101443334A Anti-viral compounds
05/26/2009US7538105 Anti-infective agents
05/22/2009WO2009064675A1 Mapk/erk kinase inhibitors
05/22/2009WO2009063993A1 Fused pyridine derivative and use thereof
05/22/2009WO2009063821A1 Heteroaryloxy quinazoline derivative
05/22/2009WO2009063180A1 Herbicidal compounds
05/22/2009WO2009040552A3 Substituted imidazo (2, 1-b) -1, 3, 4-thiazole compounds, their pharmaceutical compositions and uses thereof
05/22/2009WO2008136815A3 5, 6-ring annulated indole derivatives and use thereof
05/22/2009CA2705452A1 Mapk/erk kinase inhibitors
05/22/2009CA2705370A1 Heteroaryloxy quinazoline derivatives
05/22/2009CA2704930A1 Herbicidal compounds
05/21/2009US20090131426 Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-urea, compositions thereof, and uses therewith
05/21/2009US20090131424 Thiazolyl-dihydro-chinazoline
05/21/2009US20090131418 Spiroazacyclic compounds as monoamine receptor modulators
05/21/2009US20090130077 Substituted benzoazole pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders
05/20/2009EP1773348A4 Tetrapeptide analogs
05/20/2009CN101437816A 2-aminopyridine analogs as glucokinase activators
05/20/2009CN101437512A Glucokinase activators
05/19/2009US7534801 Piperidinylchromen-6-ylsulfonamide compounds as 5-hydroxytryptamine-6 ligands
05/19/2009US7534793 (R)-2-{4-[(1H-Indol-2-ylmethyl)-amino]-piperidin-1-yl}-1-(6-methoxyquinolin-4-yl)-ethanol; effective against both gramnegative and grampositive bacteria
05/19/2009US7534787 Method of treating diseases and conditions associated with an altered level of amyloid beta peptides and new enolcarboxamide compounds
05/19/2009CA2338651C Pyrrolo[2,1-b][1,3]benzothiazepines with atypical antipsychotic activity
05/14/2009WO2009061453A1 Solubilized thiazolopyridines
05/14/2009WO2009060054A1 Triazole derivatives as scd inhibitors
05/14/2009WO2008156869A3 Sirtuin modulating thiazolopyridine compounds
05/14/2009WO2008060626A3 Compounds for modulating trpv3 function
05/14/2009WO2007067711A3 Certain chemical entities, compositions, and methods for modulating trpv1
05/14/2009US20090124595 Mapk/erk kinase inhibitors
05/14/2009CA2705138A1 Solubilized thiazolopyridines
05/13/2009EP2057171A1 Selective glycosidase inhibitors and uses thereof
05/13/2009EP2057162A2 Fused heterocyclic inhibitors of d-amino acid oxidase
05/13/2009EP2057159A1 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
05/13/2009CN101432389A Material for organic electroluminescence element, and organic electroluminescence element
05/13/2009CN101429200A Tricyclic benzopyran compound as anti-arrhythmic agents
05/13/2009CN100486967C 5HT2C receptor modulators
05/12/2009US7531536 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease
05/12/2009CA2517933C Novel fused heteroaromatic compounds as transforming growth factor (tgf) inhibitors
05/07/2009WO2009059077A1 Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function
05/07/2009WO2009055917A1 Inhibitors of histone deacetylase
05/07/2009WO2009037001A3 Novel tetrahydrofusedpyridines as histone deacetylase inhibitors
05/07/2009WO2009018065A3 Novel glucokinase activators and methods of using same
05/07/2009US20090118275 Thiazolopyrimidine p13k inhibitor compounds and methods of use
05/07/2009US20090118272 Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors
05/07/2009US20090117040 Novel pharmaceutical and diagnostic compositions for use in the treatment and diagnosis of neurodegenerative diseases or amyloid diseases
05/07/2009US20090113639 For coloring keratin fibers, human hair
05/07/2009CA2703718A1 Inhibitors of histone deacetylase
05/06/2009EP2054420A1 Benzimidazoý1,2-c¨ý1,2,3¨thiadiazol-7-sulfonamides as inhibitors of carbonic anhydrase and the intermediates for production thereof
05/06/2009EP2054404A1 Imidazole compounds having an antiinflammatory effect
05/06/2009EP1704154B1 Novel indeno [2,1a]indenes and isoindol [2,1-a]indoles
05/06/2009CN101426486A Compounds for the treatment of inflammatory disorders and microbial diseases
05/06/2009CN101423481A Diketohydrazine derivative compound and medicine containing the compound as active ingredient
05/06/2009CN100484944C N4-substited pyrazolyl [4,5-e][1,2,4] thiadiazine derivative and its preparation process and medicine composition
05/05/2009US7528160 {6-[5-Methyl-2-(4-trifluoromethyl-phenyl)-oxazol-4-ylmethoxy]-benzo[b]thiophen-3-yl}-acetic acid; antidiabetic agent; metabolic Syndrome, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis; lowering fibrinogen, increasing HDL levels
05/05/2009US7528148 Pyrazolo[3,4-B]pyridine compounds, and their use as phosphodiesterase inhibitors
05/05/2009US7528147 e.g. 2 {5,6-dimethoxy-1-[2-(4-methylpiperazin- 1 -yl)ethyl]-1H-indol-3 -yl}-1H-pyrrolo[2,3- b]pyridine; Insulin Growth Factor-1 (somatomedin) antagonist; antiproliferative, antitumor agent; solid tumor; prostate, lung and breast cancer
04/2009
04/30/2009WO2009053378A1 Process for the preparation of 6-substituted-imidazo [2,1-b] thiazole-5-sulfonyl halide
04/30/2009WO2008020438A3 Benzothiazolyl thienopyridine derivatives and uses thereof
04/30/2009US20090111151 Production of Polyketides
04/30/2009US20090108733 Precursors of Organometallic Compounds for Electroluminescent Materials
04/30/2009CA2703300A1 Process for the preparation of 6-substituted-imidazo [2,1-b] thiazole-5-sulfonyl halide
04/29/2009EP2053052A1 Process for the preparation of 6-substituted imidazo[2,1-b]thiazole-5-sulfonyl halide
04/29/2009EP2051985A2 Pyrazolo[4,3-d]thiazole derivatives, and preparation and therapuetic application thereof
04/29/2009EP1537123B1 Amino-substituted cyclohexane derivatives for the treatment of bacterial infections
04/29/2009CN101421281A Substituted imidazo[2,1-b]thiazole compounds and their use for producing drugs
04/29/2009CN101421279A Imidazo compounds
04/29/2009CN101421278A Condensed imidazole derivatives as aldosterone synthase inhibitors
04/29/2009CN101421273A Spiro-imidazo compounds
04/29/2009CN101421265A Thiazole compounds as protein kinase b (pkb) inhibitors
04/29/2009CN101418005A Novel method for synthesizing prulifloxacin
04/29/2009CN101418004A Process for producing thiazole derivative
04/29/2009CN100482229C Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
04/28/2009US7524951 Intermediates of 2-substituted carbapenem derivatives and process for production thereof
04/28/2009US7524864 Methods of treating sleep disorders
04/28/2009US7524860 Antibacterial agents
04/23/2009WO2009051244A1 Heterocyclic compound
04/23/2009WO2009049476A1 Process for the manufacture of (+)-biotin
04/23/2009WO2009017822A3 Pi3 kinase modulators and methods of use
04/23/2009US20090105246 Sirtuin modulating compounds
04/22/2009EP2049548A1 Fused oxazoles & thiazoles as histamine h3- receptor ligands
04/22/2009EP1387842B1 Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors
04/22/2009CN101415716A Condensed imidazole derivatives as aldosterone synthase inhibitors
04/22/2009CN101415710A Bicyclic imidazole or thiadiazole heterocycles useful as selective androgen receptor modulators
04/22/2009CN101415708A HIV inhibiting 3,4-dihydro-imidazo[4,5-b]pyridin-5-ones
04/21/2009US7521462 4-Amino-piperidine derivatives as monoamine uptake inhibitors
04/21/2009US7521460 e.g. 3-[(2,4-Difluorophenyl)amino]-2-{[(2R)-2-(hydroxymethyl)pyrrolidin-1-yl]carbonyl}-7-phenylthieno[2,3-b]pyridin-6(7H)-one; autoimmune, neurodegenerative disorders, antiinflammatory agent; p38 MAP kinase inhibitor
04/16/2009WO2008047952A3 Antidepressant, neuroprotectant, amyloid beta deposition inhibitor or age retardant containing heterocyclic compound
04/16/2009WO2008015340A3 Pyrazolo[4,3-d]thiazole derivatives, and preparation and therapuetic application thereof
04/16/2009WO2006047507A3 Phosphonate substituted kinase inhibitors
04/16/2009US20090099163 Glucokinase activators
1 ... 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 ... 152